Medical devices, healthcare technology and the business of care
PMA approval · P190023

Portico Transcatheter Aortic Valve Implantation System

ABBOTT MEDICAL · Decision date Sep 17, 2021

FDA DECISIONP190023

What did the FDA approve?

FDA records P190023 as an original PMA application. The recorded decision is approval, dated Sep 17, 2021.

FDA approval order statement

Approval for the Portico Transcatheter Aortic Valve Implantation System. The device is indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality >= 8% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical comorbidities unmeasured by the STS risk calculator).
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Sep 17, 2021

FDA source record

Regulatory record facts

Identifier
P190023
Regulatory pathway
Premarket approval application
Product code
NPT
Decision code
APPR
Decision date
Sep 17, 2021
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Aortic valve, prosthesis, percutaneously delivered.

Product code
NPT
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P190023 received

    Application receipt date recorded by FDA.

  2. P190023 · FDA decision

    APPR

  3. P190023/S033 · Related supplement

    Navitor Transcatheter Aortic Valve Implantation System

Timeline entries are records held by MedtechLedger for P190023. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P190023

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 29, 2026FDA

Explore the linked device profile

Other records with product code NPT

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
177 County Rd. B E., St. Paul, MN, 55117

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records